Han et al. 2022 — The Potential Prebiotic Berberine Combined With Methimazole Improved the Therapeutic Effect of Graves' Disease Patients Through Regulating the Intestinal Microbiome
Han Z, Cen C, Ou Q, Pan Y, Zhang J, Huo D, Chen K
Share & cite
Links open in a new tab.
Citation record
- Year
- 2022
- Journal
- Frontiers in Immunology
- WikiBiome key
han-2022-berberine-methimazole-graves-microbiome
Used in 9 visible records
microbeEnterobacter→microbeEnterococcus→microbeFaecalibacterium prausnitzii→microbeFaecalibacterium→diseaseGraves' Disease→metalIron→microbeLactococcus→defenseSiderophores→interventionBerberine→Researcher discussion
0 postsConnect the evidence
Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.
No discussion yet. Start with a precise question or a source-backed observation.
Transparent record
0 eventsActivity and accepted changes
Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.
No public collaboration activity has been recorded for this page yet.